PAVmed (PAVM) Other Non-Current Assets (2016 - 2025)
PAVmed's (PAVM) quarterly Other Non-Current Assets came in at $56000.0 in Q4 2025, down 73.08% year-on-year from $208000.0 in Q4 2024, and down 78.63% quarter-over-quarter from $262000.0 in Q3 2025.
PAVmed (PAVM) Other Non-Current Assets (2016 - 2025) Analysis & Trends
PAVmed's Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $56000.0 for Q4 2025.
- On a quarterly basis, Other Non-Current Assets fell 73.08% year-over-year to $56000.0 in Q4 2025; TTM through Dec 2025 was $56000.0, a 73.08% decrease from a year earlier, with the FY2025 full-year figure at $56000.0, down 73.08% from the prior year.
- Other Non-Current Assets declined to $56000.0 in Q4 2025 per PAVM's latest filing, from $262000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.9 million in Q2 2024 and bottomed at $51000.0 in Q1 2025.
- The 5-year median for Other Non-Current Assets is $948000.0 (2021), against an average of $841200.0.
- Across the five-year window, Other Non-Current Assets soared 342.31% in 2021 and tumbled 95.55% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $725000.0 in 2021, then jumped by 54.62% to $1.1 million in 2022, then rose by 2.32% to $1.1 million in 2023, then tumbled by 81.87% to $208000.0 in 2024, then sank by 73.08% to $56000.0 in 2025.
- Per Business Quant, the three latest PAVM Other Non-Current Assets figures stand at $56000.0 (Q4 2025), $262000.0 (Q3 2025), and $373000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | 56,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 262,000.00 |
| Jun 30, 2025 | 373,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 208,000.00 |
| Sep 10, 2024 | 379,000.00 |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.15 Mn |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 695,000.00 |
| Dec 31, 2021 | 725,000.00 |
| Sep 30, 2021 | 755,000.00 |
| Jun 30, 2021 | 1.04 Mn |
| Mar 31, 2021 | 861,000.00 |